Patrick Campbell is the senior editor of Endocrinology Network, as well as its sister publication Practical Cardiology. Prior to joining these brands, he led coverage of cardiology and diabetes with HCPLive. Before joining parent company MJH Life Sciences in 2019, he spent time as a beat reporter with the Pocono Record in Stroudsburg, PA and Star News Group in Manasquan, NJ. He also touts experience in multimedia, having spent time as a freelance multimedia specialist with NJ Advance Media and multimedia coordinator at the Pocono Record. In his free time, he enjoys traveling, sports, and exploring the great outdoors. Follow him on Twitter @RealPatCampbell or reach him via email at PCampbell@mjhlifesciences.com.

Videos

Juan Frias, MD, breaks down results of a post-hoc analysis of the AWARD-11 study examining expanded doses of dulaglutide according to baseline HbA1c levels.

Expanded Doses of Dulaglutide Safe, Efficacious Regardless of Baseline HbA1c

Learn more about once-weekly basal insulin Fc from Eli Lilly and Company in this interview with the lead investigator from their phase 2 trial, which was presented at ENDO 2021.

Once-Weekly Basal Insulin Fc Shows Promise in Phase 2 Trial

Principal investigator of the SURPASS-2 trial discusses the results of the trial and how it informs clinicians on the use of tirzepatide versus currently approved diabetes medications. 

Tirzepatide for Reducing HbA1c and Body Weight in Type 2 Diabetes with Juan Frias, MD

Published in late February, results of the STEP 1 and STEP 3 trial give clinicians insight into the effects of 2.4 mg subcutaneous semaglutide as an intervention for weight loss in overweight or obese patients ahead of a potential approval in June 2021. 

STEP 1 and STEP 3 Results with Thomas Wadden, PhD

Experts in diabetes provide their perspective on various facets of diabetes management including the use of insulin pumps.

Insulin Therapy in Type 2 Diabetes

Learn why one organization prioritizes screening for diabetic retinopathy among patients with diabetes.

The Importance of Screening for Diabetic Retinopathy Among Patients With Diabetes

A discussion centered around optimizing the number of patients with diabetes who receive screening for diabetic retinopathy to ensure the best quality outcomes.

Diabetic Retinopathy and the Importance of Screening

Jeffrey Curtis, MD, MS, MPH, details how the perception of biphosphonates has been detrimental to efforts to improve treatment and diagnosis of osteoporosis.

Controversies in Using Bisphosphonates for Treating Osteoporosis 

An endocrinologist from Brigham and Women’s Hospital discusses the latest in diabetes management. 

Marie E. McDonnell, MD: The Latest in Diabetes Management

Jeffrey Curtis, MD, MS, MPH, offers his thoughts on the most effective methods to address the underdiagnosis and undertreatment of osteoporosis in older male patients. 

Expert Interviews